• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® ENDOPROSTHESIS WITH PROPATEN BIOACTIVE SURFACE; SYSTEM, ENDO GRAFT, ARTERIOVENOUS DIALYSIS ACCESS CIRCUIT STENOSIS TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® ENDOPROSTHESIS WITH PROPATEN BIOACTIVE SURFACE; SYSTEM, ENDO GRAFT, ARTERIOVENOUS DIALYSIS ACCESS CIRCUIT STENOSIS TREATMENT Back to Search Results
Catalog Number PAJ080502B
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Obstruction/Occlusion (2422)
Event Date 11/01/2020
Event Type  Injury  
Manufacturer Narrative
Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.Since it is not known which device, if either contributed to the occlusion, the following device is included in the report: catalog number pajr070502b lot and udi information are unknown.
 
Event Description
In an article titled " endovascular venous outflow redirection in failing arteriovenous hemodialysis access using a combination of covered and interwoven nitinol stents" it states a patient underwent treatment of an av access revision with two gore® viabahn® endoprostheses with propaten bioactive surface.Nine days following the procedure, complete thrombosis of the two gore® viabahn® endoprostheses with propaten bioactive surface occurred.The occlusion was treated by means of thrombectomy and stent relining.
 
Manufacturer Narrative
Section h6 updated to reflect completion of investigation.Further information regarding this event was requested by gore, but no further information has been reported, therefore this investigation is considered complete.
 
Manufacturer Narrative
Section a, b, d, g and h updated to reflect completion of investigation.Manufacturing records were reviewed, and the device met all pre-release specifications.The device remains in the patient.Consequently, a direct product analysis was not possible.Cause of the reported event cannot be established based on evaluation of the information reported to gore.Further information regarding this event was requested by gore, but no further information has been reported, therefore this investigation is considered complete.As the following device was used as an overlapping system it will be included in this report: gore® viabahn® endoprosthesis (serial # (b)(6); udi # (b)(4)).Simon bradette, mireille méthot, gérald gahide, myriam létourneau-montminy, catherine lalonde, françois côté, guillaume garneau, mathieu béland, endovascular venous outflow redirection in failing arteriovenous hemodialysis access using a combination of covered and interwoven nitinol stents, journal of vascular and interventional radiology, volume 31, issue 11, 2020, pages 1911-1914, issn 1051-0443,https://doi.Org/10.1016/j.Jvir.2020.07.023.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® ENDOPROSTHESIS WITH PROPATEN BIOACTIVE SURFACE
Type of Device
SYSTEM, ENDO GRAFT, ARTERIOVENOUS DIALYSIS ACCESS CIRCUIT STENOSIS TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
nick lafave
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key12298510
MDR Text Key265797168
Report Number2017233-2021-02228
Device Sequence Number1
Product Code PFV
Combination Product (y/n)Y
Reporter Country CodeCA
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 02/02/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/09/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/21/2021
Device Catalogue NumberPAJ080502B
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/02/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/22/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Other;
Patient SexFemale
Patient Weight49 KG
-
-